ACCORD BIOPHARMA
Live / Registered — Registered (as of 10 Dec 2024)
What this means for you
Registered since 10 Dec 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97298517
- Registration number
- 7592997
- Mark type
- Stylized text
- Filed
- 07 Mar 2022
- Published for opposition
- 10 Sept 2024
- Registered
- 10 Dec 2024
- Attorney of record
- Michele K. Robichaux
Goods and services
- Class 005 — Pharmaceuticals: A full line of medicated and pharmaceutical preparations, namely, pharmaceutical preparations and substances for use in the prevention, treatment and management of cancer, autoimmune diseases, immunological deficiency syndromes in the nature of autoimmune diseases, and critical illnesses in the nature of immune system related diseases and disorders for use in connection with humans
- Class 044 — Medical, beauty and agricultural services: Providing healthcare and medical information; Providing information in the fields of Oncology, Immunology, and Critical Care
Owner
- Accord BioPharma, Inc., Durham, NC, US
- Accord BioPharma, Inc., Durham, NC, US
- Accord BioPharma, Inc., Durham, NC, US
Prosecution history
- 17 Feb 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 Feb 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 17 Feb 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 10 Dec 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 10 Dec 2024 — REGISTERED-PRINCIPAL REGISTER
- 10 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Sept 2024 — PUBLISHED FOR OPPOSITION
- 21 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 May 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 May 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 May 2024 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 01 Feb 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 01 Feb 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 08 Nov 2023 — NOTIFICATION OF FINAL REFUSAL EMAILED